URACYST® LICENSE AGREEMENT This Agreement made as of 24th day of March, 2004 BETWEENUracyst® License Agreement • July 13th, 2006 • Stellar Pharmaceuticals Inc • Pharmaceutical preparations • New York
WHEREAS Stellar has developed and owns methods and technical know-how relating to the manufacture and use of their proprietary product Uracyst®, a sterile sodium chondrotin sulfate solution 2.0% in a 20 mL vial, and the Uracyst® Test Kit containing 1 vial of Solution K (sterile potassium chloride solution 3.0% and 1 vial Uracyst® 2.0%,
